Development of oral suspensions of microparticles of ethylcellulose with tramadol

Drug Development and Industrial Pharmacy

Volumn 36, Issue 8, 2010, Pages 885-892

  Morales, M E ^a   Ruiz, M A ^a   Lopez G ^a   Gallardo, V ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Ethylcellulose; Microencapsulation; Oral administration; Sustained release; Tramadol

Indexed keywords

CARBOMER; CARBOXYMETHYLCELLULOSE; ETHYL CELLULOSE; MICROCRYSTALLINE CELLULOSE; TRAMADOL; XANTHAN; BACTERIAL POLYSACCHARIDE; CELLULOSE; DELAYED RELEASE FORMULATION; DRUG CARRIER; EXCIPIENT; MICROSPHERE; NARCOTIC ANALGESIC AGENT; POLYVINYL DERIVATIVE; SUSPENSION;

ARTICLE; DRUG FORMULATION; DRUG RELEASE; IN VITRO STUDY; MICROENCAPSULATION; SCANNING ELECTRON MICROSCOPY; SPECTROPHOTOMETRY; SUSTAINED RELEASE PREPARATION; ADMINISTRATION AND DOSAGE; ANALOGS AND DERIVATIVES; ANALYSIS; CHEMISTRY; COMPARATIVE STUDY; DELAYED RELEASE FORMULATION; DIFFERENTIAL SCANNING CALORIMETRY; DIFFUSION; KINETICS; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; SURFACE PROPERTY; SUSPENSION; VISCOSITY;

ADMINISTRATION, ORAL; ANALGESICS, OPIOID; CALORIMETRY, DIFFERENTIAL SCANNING; CELLULOSE; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG CARRIERS; DRUG COMPOUNDING; EXCIPIENTS; KINETICS; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PARTICLE SIZE; POLYSACCHARIDES, BACTERIAL; POLYVINYLS; SURFACE PROPERTIES; SUSPENSIONS; TRAMADOL; VISCOSITY;

EID: 77954190532     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639040903578726     Document Type: Article

References (24)

1. Hanks GW, De Conno F, Cherny N, Hanna M, Kalso E, Mcquay HJ, et al. (2002). Morfina y opiáceos alternativos para el trata-miento del dolor oncológico: Recomendaciones de la EAPC. Med Pal, 1(9):22-29
2. Lee CR, McTavish D, Sorkin EM. (1993). Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states. Drugs, 46(2):313-340 (Pubitemid 23244649)
3. Loram LC, Mitchell D, Skosan M, Fick LG. (2007). Tramadol is more effective than morphine and amitriptyline against ischaemic pain but not thermal pain in rats. Pharmacol Res, 1(56):80-85
4. Casals M, Samper D. (2004). Effectiveness, tolerability and quality of live in the management of chronic pain unrelated to cancer with sustained-release tramadol administered in a single daily dose. Rev Soc Esp Dolor, 11:129-140
5. Garrido MJ, Habre W, Rombout F, Trocóniz IF. (2006). Population pharmacokinetic/pharmacodynamic modelling of the analgesic effects of tramadol in pediatrics. Pharm Res, 23(9):2014-2023
6. Díaz A, Zaragoza F, López-Muñoz F. (2004). Álamo C, Analgési-cos opioids (I). In: Médica A, ed. Abordaje del Dolor desde la Oficina de Farmacia (I). Medica. Madrid, España, 125-149
7. Morales ME, López G, Ruiz MA. (2007). Estudio de estabilidad de suspensions farmacéuticas de liberación modificada de clo-rhidrato de morfina. Ars Pharm, 48(2):157-173
8. Guo X, Zhang L, Oian Y, Zhou J. (2007). Effect of composition on the formation of poly(dl-lactide) microspheres for drug delivery systems: Mesoscale simulations. Chem Eng J, 131:195-201.
9. Arias JL, Gallardo V, Ruiz MA, Delgado AV. (2004). Ftorafur loading and controlled release from poly (ethyl-2-cyanocry-late) and poly (butylcyanocrylate) nanospheres. Int J Pharm, 337(1-2):195-201.
10. Babu VR, Sairam M, Hosamani KM, Aminabjavi TM. (2007). Preparation of sodium alginate-methylcellulose blend micro-spheres for controlled release of nifedipine. Carbohydr Polym, 69(2):241-250
11. Whang Q, Dong Z, Du Y, Kennedy F. (2007). Controlled release of ciprofloxacin hydrochloride from chitosan/polyethylene gly-col blend films. Carbohydr Polym, 69(2):336-343
12. Morales ME, Gallardo V, Calpena AC, Doménech J, Ruiz MA. (2004). Comparative study of morphine diffusion from sustained release polymeric suspensions. J Control Release, 95:75-81.
13. Vanderhoff JW, El-Aaser MS, Ugelstad J. (1979). Polymer emul-sification. US patent 4. 177:177.
14. Franz TJ. (1975). Percutaneous absorption on the relevance of in vitro data. J Invest Dermatol, 64(3):190-195
15. Kierstan KT, Beeper AE, Mitchell JC, Hadgraft J, Raghavan SL, Davis AF. (2001). UV-spectrophotometry study of membrane transport processes with a novel diffusion cell. Int J Pharm, 229(1-2):87-94.
16. Peppas NA, Sahlin JJ. (1989). A simple equation for the description of solute release. III. Coupling of diffusion and relaxation. Int J Pharm, 57:169-172
17. Petrov O, Furó I, Schuleit M, Dananig R, Plunket M, Daicic J. (2006). Pore size distributions of biodegradable polymer micro-particles in aqueous environments measured by NMR cry-oporometry. Int J Pharm, 309:157-162
18. Yang Y, Chung T, Bai X, Chan W. (2000). Effect of preparation conditions on morphology and release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion method. Chem Eng Sci, 55:2223-2236
19. Rosca ID, Watari F, Uo M. (2004). Microparticle formation and its mechanism in single and double emulsion solvent evaporation. J Control Release, 99:271-280
20. Luan X, Bodmeier R. (2006). In situ forming microparticle system from controlled delivery of leurolide acetate: Influence of the formulation and processing parameters. Eur J Pharm Sci, 27(2-3):143-149
21. Domenech J, Martínez J, Plá JM. (1998). Biofarmacia y Farma-cocinética II. Síntesis. Madrid, Spain.
22. Rudraraju VS, Wyand C. (2005). Rheological characterization of microcrystalline cellulose/sodiumcarboxymethyl cellulose hydrogels using a controlled stress rheometer. Part I and II. Int J Pharm, 292:53-61.
23. Matthews BA, Rhodes CT. (1970). Use of the Derjaguin, Landau, Verwey and Overbeek theory to interpret pharmaceutical suspension stability. J Pharm Sci, 59:521-528
24. Morales ME, Gallardo V, López G, Atienza M, Martín R, Ruíz MA. (2006). Estabilidad de una formulación oral líquida de morfina para pediatría. Farm Hosp, 30:1-4.